CVRx (CVRX) Interest Coverage Ratio Growth (1y) (2021 - 2026)
CVRx (CVRX) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.91% |
| 10 | CVRx | 77.03 Mn | 12.44 Mn | 13.72 Mn | 15.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.88% |
| Mar 31, 2026 | 14.98% |
| Dec 31, 2025 | 11.04% |
| Sep 30, 2025 | -75.84% |
| Jun 30, 2025 | -1,105.65% |
| Mar 31, 2025 | -1,439.33% |
| Dec 31, 2024 | 83.84% |
| Sep 30, 2024 | -548.82% |
| Jun 30, 2024 | -87.83% |
| Mar 31, 2024 | 96.15% |
| Dec 31, 2023 | 71.79% |
| Sep 30, 2023 | 73.22% |
| Jun 30, 2023 | 84.62% |
| Mar 31, 2023 | 68.61% |
| Dec 31, 2022 | -1,443.10% |
| Sep 30, 2022 | -233.06% |
| Jun 30, 2022 | -2,513.13% |
| Mar 31, 2022 | -606.04% |
| Dec 31, 2021 | -198.23% |
| Sep 30, 2021 | 94.16% |